Literature DB >> 24699413

The Batten disease gene CLN3 confers resistance to endoplasmic reticulum stress induced by tunicamycin.

Dan Wu1, Jing Liu2, Baiyan Wu2, Bo Tu3, Weiguo Zhu3, Jianyuan Luo4.   

Abstract

Mutations in CLN3 gene cause juvenile neuronal ceroid lipofuscinosis (JNCL or Batten disease), an early-onset neurodegenerative disorder that is characterized by the accumulation of ceroid lipofuscin within lysosomes. The function of the CLN3 protein remains unclear and is presumed to be related to Endoplasmic reticulum (ER) stress. To investigate the function of CLN3 in the ER stress signaling pathway, we measured proliferation and apoptosis in cells transfected with normal and mutant CLN3 after treatment with the ER stress inducer tunicamycin (TM). We found that overexpression of CLN3 was sufficient in conferring increased resistance to ER stress. Wild-type CLN3 protected cells from TM-induced apoptosis and increased cell proliferation. Overexpression of wild-type CLN3 enhanced expression of the ER chaperone protein, glucose-regulated protein 78 (GRP78), and reduced expression of the proapoptotic protein CCAAT/-enhancer-binding protein homologous protein (CHOP). In contrast, overexpression of mutant CLN3 or siRNA knockdown of CLN3 produced the opposite effect. Together, our data suggest that the lack of CLN3 function in cells leads to a failure of management in the response to ER stress and this may be the key deficit in JNCL that causes neuronal degeneration.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CLN3; Endoplasmic reticulum (ER) stress; JNCL; Tunicamycin

Mesh:

Substances:

Year:  2014        PMID: 24699413     DOI: 10.1016/j.bbrc.2014.03.120

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  6 in total

1.  Unbiased Cell-based Screening in a Neuronal Cell Model of Batten Disease Highlights an Interaction between Ca2+ Homeostasis, Autophagy, and CLN3 Protein Function.

Authors:  Uma Chandrachud; Mathew W Walker; Alexandra M Simas; Sasja Heetveld; Anton Petcherski; Madeleine Klein; Hyejin Oh; Pavlina Wolf; Wen-Ning Zhao; Stephanie Norton; Stephen J Haggarty; Emyr Lloyd-Evans; Susan L Cotman
Journal:  J Biol Chem       Date:  2015-04-15       Impact factor: 5.157

Review 2.  Neuronal Ceroid Lipofuscinosis: Potential for Targeted Therapy.

Authors:  Nicola Specchio; Alessandro Ferretti; Marina Trivisano; Nicola Pietrafusa; Chiara Pepi; Costanza Calabrese; Susanna Livadiotti; Alessandra Simonetti; Paolo Rossi; Paolo Curatolo; Federico Vigevano
Journal:  Drugs       Date:  2021-01       Impact factor: 9.546

3.  Advances in the Treatment of Neuronal Ceroid Lipofuscinosis.

Authors:  Jonathan B Rosenberg; Alvin Chen; Stephen M Kaminsky; Ronald G Crystal; Dolan Sondhi
Journal:  Expert Opin Orphan Drugs       Date:  2019-11-27       Impact factor: 0.694

4.  RNAi-mediated knockdown of the CLN3 gene inhibits proliferation and promotes apoptosis in drug-resistant ovarian cancer cells.

Authors:  Dongwei Mao; Jianhua Che; Shiyu Han; Honghui Zhao; Yumei Zhu; Hong Zhu
Journal:  Mol Med Rep       Date:  2015-08-21       Impact factor: 2.952

5.  Lack of specificity of antibodies raised against CLN3, the lysosomal/endosomal transmembrane protein mutated in juvenile Batten disease.

Authors:  Tarah Nelson; David A Pearce; Attila D Kovács
Journal:  Biosci Rep       Date:  2017-11-23       Impact factor: 3.840

Review 6.  NCLs and ER: A stressful relationship.

Authors:  Davide Marotta; Elisa Tinelli; Sara E Mole
Journal:  Biochim Biophys Acta Mol Basis Dis       Date:  2017-04-06       Impact factor: 5.187

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.